LivaNova (LIVN) Lifted to Buy at ValuEngine

LivaNova (NASDAQ:LIVN) was upgraded by ValuEngine from a “hold” rating to a “buy” rating in a note issued to investors on Friday.

Several other equities analysts have also recently issued reports on LIVN. BidaskClub raised LivaNova from a “hold” rating to a “buy” rating in a research report on Friday, January 26th. Zacks Investment Research cut LivaNova from a “hold” rating to a “strong sell” rating in a research report on Thursday, January 25th. Needham & Company LLC upped their price objective on LivaNova from $93.00 to $97.00 and gave the company a “buy” rating in a research report on Tuesday, December 5th. BTIG Research reaffirmed a “hold” rating on shares of LivaNova in a research report on Tuesday, November 7th. Finally, Jefferies Group upped their price objective on LivaNova from $80.00 to $91.00 and gave the company a “buy” rating in a research report on Friday, November 3rd. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $79.71.

Shares of LivaNova (NASDAQ LIVN) traded up $0.04 on Friday, hitting $85.72. The stock had a trading volume of 396,080 shares, compared to its average volume of 338,484. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.42 and a current ratio of 2.03. LivaNova has a 12-month low of $45.67 and a 12-month high of $88.56. The company has a market cap of $4,132.73, a PE ratio of 73.27, a P/E/G ratio of 2.54 and a beta of 0.83.

LivaNova (NASDAQ:LIVN) last issued its quarterly earnings results on Thursday, November 2nd. The company reported $0.93 EPS for the quarter, topping analysts’ consensus estimates of $0.76 by $0.17. The firm had revenue of $309.70 million for the quarter, compared to analysts’ expectations of $301.22 million. LivaNova had a return on equity of 9.33% and a net margin of 4.63%. The business’s revenue for the quarter was up 4.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.78 EPS. sell-side analysts forecast that LivaNova will post 2.93 EPS for the current fiscal year.

In other news, Director Daniel Jeffrey Moore sold 1,000 shares of the stock in a transaction on Wednesday, November 15th. The stock was sold at an average price of $81.39, for a total transaction of $81,390.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Alfred J. Novak sold 2,000 shares of the stock in a transaction on Wednesday, November 22nd. The shares were sold at an average price of $85.77, for a total value of $171,540.00. The disclosure for this sale can be found here. Insiders sold a total of 6,830 shares of company stock worth $576,920 over the last ninety days. 0.28% of the stock is currently owned by insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. PNC Financial Services Group Inc. lifted its holdings in shares of LivaNova by 9.8% during the 2nd quarter. PNC Financial Services Group Inc. now owns 1,707 shares of the company’s stock valued at $105,000 after buying an additional 153 shares during the period. Strs Ohio lifted its holdings in shares of LivaNova by 2.9% during the 4th quarter. Strs Ohio now owns 21,100 shares of the company’s stock valued at $1,686,000 after buying an additional 600 shares during the period. Thrivent Financial For Lutherans lifted its holdings in shares of LivaNova by 7.6% during the 2nd quarter. Thrivent Financial For Lutherans now owns 8,770 shares of the company’s stock valued at $537,000 after buying an additional 620 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of LivaNova by 9.7% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,274 shares of the company’s stock valued at $578,000 after buying an additional 643 shares during the period. Finally, Riverhead Capital Management LLC lifted its holdings in shares of LivaNova by 76.3% during the 2nd quarter. Riverhead Capital Management LLC now owns 1,763 shares of the company’s stock valued at $108,000 after buying an additional 763 shares during the period. 86.01% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: This story was originally posted by American Banking News and is the property of of American Banking News. If you are reading this story on another publication, it was copied illegally and republished in violation of U.S. and international copyright laws. The legal version of this story can be viewed at https://www.americanbankingnews.com/2018/02/04/livanova-livn-lifted-to-buy-at-valuengine.html.

LivaNova Company Profile

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for LivaNova (NASDAQ:LIVN)

Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply